404
+1-313-307-4176
GI Stool Testing Market Report
Global GI Stool Testing Market, Dynamics, Market Analysis
The report on the Global GI Stool Testing Market is segmented, By Product (Instruments, Reagents), By Test Type (Occult Blood Test, Ova and Parasites Test, Bacteria Test, Fecal Biomarkers Test, Other Test Types), By End Use (Hospitals, Diagnostic Centers And Laboratories, Academic Institutions, Research Centers & Organizations, Home) and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global GI stool testing market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The Global GI Stool Testing Market is projected to grow from USD xx million in 2020 to USD xx million by 2026 at a CAGR of over 7.4% during the forecast period.
Figure: Global GI Stool Testing Market Size, 2020-2026 (USD Million)
Wish to get a free sample? Register Here
Gastrointestinal (GI) disorders are highly common among the populace and can cause severe harm to digestive health. GI stool testing is the diagnosis of stool or feces samples to detect or analyze digestive tract diseases or infections. GI disorders consist of various diseases such as malabsorption, bowel inflammation, and cancer, among others. These tests are performed to diagnose GI tract disorders and help in the detection of parasite infection and bleeding obstruction.
Key players operating in the global GI stool testing market are-
The growing healthcare awareness and rising healthcare expenditure by the government & private sector are likely to bolster the product demand.
Based on the product, the global GI stool testing market has been bifurcated into instruments and reagents.
By region, the North America market witnessed the highest market share in 2020 and is projected to grow at a robust CAGR during the review period.
The COVID-19 pandemic has significantly affected the GI stool testing industry due to the shift of medical treatment from gastrointestinal disorders towards soaring coronavirus-affected patients. Moreover, the healthcare expenditure has been used for the production of the COVID-19 vaccine, resulting in less R&D in product innovation. Also, the appointments of the GI disorder patients were either delayed or postponed, thus affecting the market growth.
Want to know the full scope of the report? Register Here
Here is the list of the group of customers that the GI Stool testing market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
The GI stool testing market is expected to witness an impressive growth of 7.4% CAGR in the foreseeable future.
Abbott Laboratories (The US), Beckman Coulter Inc. (The US), bioMerieux SA (France), Cardinal Health (The US), Cenogenics Corporation (The US), CTK Biotech Inc. (The US), Genova Diagnostics (The US), Epitope Diagnostics Inc. (The US), ScheBo Biotech AG (Germany), and MERIDIAN BIOSCIENCE INC. (The US) are among the key players in the GI stool testing market.
The growing healthcare awareness and rising healthcare expenditure by the government & private sector, The increasing prevalence of GI health disorders owing to rising consumption of fast food, stress & hectic lifestyle, as well as the growing geriatric population who are highly susceptible to GI infections are the factors driving the growth of GI stool testing market.
North America market witnessed the highest market share in 2020 and is projected to grow at a robust CAGR during the review period.
The reagents segment accounted for the highest market share in 2020 and is likely to register a steady CAGR during the review period.
GI stool testing companies, Hospitals, Diagnostic Centers And Laboratories, Academic Institutions, Research Centers & Organizations are the target audience in the GI stool testing market.
WE ACCEPT
